NORML

MARCH 23, 2020

Yet despite these and other claims , including those spreading on social media , there is as of yet no substantiated clinical data supporting either the prophylactic or therapeutic use of cannabis products in the treatment of COVID-19. A greater discussion of these cannabis safety guidelines are available from NORML here.).

CBD 347

CBD Therapy Treatment Packaging 347

Veriheal

AUGUST 31, 2020

It brings us great pleasure to present the 10 winners of Veriheal’s Innovation in Cannabis Scholarship 2020. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Nishtha Tripathi. School: George Washington University.

Research and Development 117

Research and Development Education Agriculture Patients 117

Veriheal

FEBRUARY 3, 2021

The gaining acceptance of cannabis in a legal sense allows researchers to study and perform testing on cannabis in order to get a better understanding of its mechanisms, safety, and efficacy. This is a major win for cancer patients as it provides an alternative treatment that is not effective by means of potent chemicals. .

Consumption 52

Consumption Safety THC Cannabis 52

NORML

MAY 26, 2020

A team of Israeli researchers conducted a randomized placebo-controlled clinical trial to assess the safety and efficacy of a novel, metered-dose cannabis inhaler in 27 patients with chronic pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo.

Clinical Trials 252

Clinical Trials Chronic Pain Cannabinoids Patients 252

CannaMD

APRIL 19, 2020

As the coronavirus crisis continues, CannaMD remains committed to helping patients access treatment as safely as possible. Of the utmost importance, however, is the overall health and safety of our patients and Medtenders. Offer valid April 16-30, 2020. This offer is available April 17-20, 2020. Find Out if You Qualify.

Seed-To-Sale 65

Seed-To-Sale Marijuana Wellness and Beauty Patients 65

TheAnswerPage

MARCH 20, 2023

Has the use of a transdermal gel for regional and systemic delivery of CBD been evaluated for the treatment of epilepsy? A transdermal gel for regional and systemic delivery of CBD (Zynerba Pharmaceuticals) is in clinical development for treatment of epilepsy, developmental and epileptic encephalopathy, fragile-X syndrome, and osteoarthritis.

Epilepsy 52

Epilepsy Topical Safety Treatment 52

PrestoDoctor

OCTOBER 23, 2023

THCjd is a recent cannabinoid discovery as of 2020. It’s also worth mentioning that the safety of THCjd depends on various factors. Research on THCjd is still limited, and therefore, its safety profile is not yet fully understood. However, research on the specific benefits and effects of THCjd is still in the works.

Cannabinoids 98

Cannabinoids Research and Development Safety THC 98

TheAnswerPage

JUNE 12, 2022

Has the use of a transdermal gel for regional and systemic delivery of CBD been evaluated for the treatment of epilepsy? A transdermal gel for regional and systemic delivery of CBD (Zynerba Pharmaceuticals) is in clinical development for treatment of epilepsy, developmental and epileptic encephalopathy, fragile-X syndrome, and osteoarthritis.

Epilepsy 52

Epilepsy Topical Safety Treatment 52

Cannabis Law Report

FEBRUARY 23, 2020

The Observer— Complete CBD Oil Guide 2020. CBD Oil Guide 2020. CBD can be added to edibles, topical treatment , oils and even drinks. The FDA has recently approved a drug, Epidiolex, to be used as a treatment for epilepsy in children. Safety is critical when it comes to trying any new product. by Todd Dunsmore.

Oil 66

Oil CBD Blood Pressure Hemp 66

Veriheal

DECEMBER 15, 2021

Published in the Journal of Medical Internet Research, the fresh data suggests that the cannabinoids found in cannabis, such as THC and CBD , may have potential as a treatment for sleep deprivation. The team concluded that the observed improvement in insomnia symptoms demonstrates the cannabis plant’s suitability as a treatment option.

Sleep 95

Sleep Cannabinoids Therapy Treatment 95

TheAnswerPage

OCTOBER 11, 2021

Has the use of a transdermal gel for regional and systemic delivery of CBD been evaluated for the treatment of epilepsy? A transdermal gel for regional and systemic delivery of CBD (Zynerba Pharmaceuticals) is in clinical development for treatment of epilepsy, developmental and epileptic encephalopathy, fragile-X syndrome, and osteoarthritis.

Epilepsy 52

Epilepsy Topical Safety Treatment 52

Veriheal

AUGUST 16, 2023

In an unprecedented move that embraces the evolving landscape of sports health and wellness, the National Football League (NFL) has recently made a significant investment in cannabidiol (CBD) research, aiming to explore its potential as a pain treatment alternative for players suffering from concussions.

CBD 88

CBD Research and Development Treatment Policy 88

Cannabis Law Report

AUGUST 22, 2021

Unlike competitors administering generic psychedelics, the company’s patented technology could improve safety and efficacy while guaranteeing market exclusivity. The company believes that the same homing peptide approach could improve the safety and efficacy of psychedelic treatments. Bringing Products to Market.

Clinical Trials 105

Clinical Trials Research and Development Safety Treatment 105

Veriheal

JULY 23, 2020

According to the Oregon Cannabis Association (OCA) , police budgets received more than $2 million directly from cannabis tax proceeds last year – despite the city passing a measure in 2016 stipulating that those funds should be designated for substance misuse treatment, public safety, and small business development.

Research and Development 93

Research and Development Safety Treatment Cannabis 93

Canna Law Blog

FEBRUARY 24, 2020

Last November, proponents (Decriminalize California) submitted the California Psilocybin Decriminalization Initiative 2020 , which seeks to “decriminalize psychedelic mushrooms in California by submitting a citizens initiative to be placed on the ballot for the November 3, 2020 election, to the Office of the Attorney General.”

Decriminalization 130

Decriminalization Therapy Research and Development Treatment 130

CannaMD

FEBRUARY 13, 2021

As Pryor wrote in a memo: Prosecuting these cases has no public safety value and is a costly and counterproductive use of limited resources. A 2020 study published in Nature Medicine found “an association between maternal cannabis use in pregnancy and the incidence of autism spectrum disorder in the offspring.” Get Started.

Marijuana 112

Marijuana Blood Pressure Safety Dispensary 112

Cannabis Law Report

DECEMBER 22, 2019

But it has become apparent that doctors are unwilling to take the responsibility without more evidence on the effects and safety. Living with or caring for someone with severe epilepsy is exceptionally challenging, especially as there are so few treatments available for the rare forms of the condition. Source: [link].

Epilepsy 59

Epilepsy Medicine Treatment Pharmaceutical 59

CannaMD

JUNE 2, 2020

Rochester, specifically, passed a law on May 12, 2020, which no longer requires city employees to take pre-employment marijuana drug screening tests, except when applying for safety-sensitive positions, such as commercial driving and police officer positions. Exceptions were again made for safety-sensitive positions.

Marijuana 98

Marijuana Safety Policy Advocacy 98

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

SEPTEMBER 25, 2019

Matching Funds to the 2020 Psilocybin Service Initiative. The intent of the 2020 Psilocybin Service Initiative of Oregon is to pass the Oregon Psilocybin Services Act and advance a breakthrough therapeutic model currently being perfected in research settings at top universities around the world. Here’s the release in full.

Therapy 40

Therapy Pharmaceutical Research and Development Agriculture 40

Puff Puff Post

MARCH 10, 2020

” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial. SOURCE InMed Pharmaceuticals Inc.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

The Cannigma

JANUARY 21, 2021

It is often called “the mother of all cannabinoids,” and it holds potential as a treatment for conditions such as diabetes, ALS, and Huntington’s disease, although human studies are seriously lacking. And unlike THC and CBD, there’s practically no scientific information about the safety or dosing of CBG-dominant products.

Research and Development 145

Research and Development Blood Pressure Conditions Cannabinoids 145

Cannabis Law Report

MARCH 29, 2020

March 27, 2020. In the interest of public safety, cash payments will only be accepted inside the facility. The Commission issued the order temporarily authorizing the activity pursuant to the Administration’s declaration and essential services and revised gatherings order that deemed MTC services essential to the Commonwealth.

Safety 59

Safety Treatment Patients Cannabis 59

Cannabis Law Report

JANUARY 26, 2022

The progress they have made since 2020 has been extraordinary. drugs that lack “accepted safety” for use under medical supervision. Before the federal government classified psilocybin as Schedule I in 1970, indigenous populations had used it (and other entheogens) as a medical treatment for thousands of years.

Legalization 52

Legalization Treatment Decriminalization Pharmaceutical 52

TheAnswerPage

OCTOBER 14, 2020

According to the National Academies of Science, Engineering and Medicine’s 2020 publication, A Review of the Safety and Effectiveness of Select Ingredients in Compounded Topical Pain Creams , “there is insufficient evidence on the effectiveness of topical cannabidiol to treat pain when applied to intact skin. See Answer.

Topical 52

Topical Safety Treatment Medicine 52

Veriheal

JANUARY 18, 2023

The lack of regulation has raised concerns about consumer safety. The 13-year-old girl lost her life in April 2020 after a long battle with Dravet syndrome. After exhausting alternative treatment options, her mother Paige desperately started looking for a way to improve Charlotte’s quality of life.

CBD 79

CBD Strains Research and Development Oil 79

Veriheal

MARCH 31, 2023

All that being said, the study also uncovered a few symptoms that were not improved by the cannabis treatment. While the study’s findings are promising, researchers say that more studies are necessary to evaluate the efficacy and safety of these cannabis treatments. What do you think of this Tourettes study’s findings?

Legalization 52

Legalization Chronic Pain Decriminalization Patients 52

Cannabis Law Report

JUNE 25, 2021

billion in 2020 to $1.61 The European Medicines Agency (EMA) is the regulatory body that evaluates and supervises the production and sales of medicines for safety and benefit of the customer, in the European Union Region. Global Skin Cancer Drugs Historic Market, 2015-2020, $ Billion. Key Topics Covered: 1. Executive Summary.

Research and Development 84

Research and Development Therapy Pharmaceutical Clinical Trials 84

Cannabis Law Report

AUGUST 12, 2021

loss per share, during the same period in 2020 (after including non-cash share-based compensation expense of $11.4 Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. million during the same period in 2020. million, or $0.79

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

AUGUST 24, 2021

The Company has previously successfully completed a Phase 1 first-in-human safety and tolerability study for FSD-201 and the compound to be safe with no serious adverse side effects.

Clinical Trials 105

Clinical Trials Treatment Pharmaceutical Concentrates 105

Veriheal

AUGUST 31, 2022

Dr. Alex Harocopos, who wrote a research letter on the prevention centers, explains that New York had 2,062 overdose fatalities in 2020, which the doctor describes as the deadliest year on record. These benefits include: Increasing rates of substance use disorder treatment as well as increasing rates of medical and social services.

Consumption 99

Consumption Data Treatment Collective 99

The Blunt Truth

MAY 26, 2020

First, in early March 2020, FDA Commissioner Stephen Hahn issued a statement updating the public on the agency’s work. To that end, the FDA followed up with another piece of public guidance in late April, informing the public that there are currently no approved treatments for COVID-19. Federal Court Litigation.

CBD 103

CBD Hemp Programs Food 103

Cannabis Law Report

JUNE 5, 2021

This is the second stand-alone delivery license that EE/SE Participants are eligible to apply for, after the Marijuana Courier (formerly Delivery Only) license became available in May 2020. The CCC has released draft regulations indicating where delivery service is available.

Retail 66

Retail Safety Treatment Cannabis 66

Veriheal

MARCH 1, 2022

Oregon voters approved Measure 109 in November 2020 which has given birth to this program. In addition to navigating federal illegality, Oregon’s Psilocybin Advisory Board is tasked with laying the framework for maximizing safety training, as well as ensuring program remains equitable, affordable, and accessible for anyone who needs it.

Therapy 98

Therapy Programs Microdosing Medicine 98

Cannabis Law Report

FEBRUARY 20, 2020

The budtenders at the British Columbia-based dispensary chose to join UFCW 1518 “in an effort to address outstanding concerns, including fair wages, a respectful workplace, safety and security on the job, and education and training opportunities,” the organization said in a press release. February 18, 2020 12:50 ET | Source: UFCW 1518.

Education 59

Education Safety Dispensary Food 59

Cannabis Law Report

NOVEMBER 1, 2021

November 2020 – April 2021. Read the full submission – Consultation: Proposed amendments to the Poisons Standard – ACMS, ACCS and Joint ACMS/ACCS meetings, November 2020. RANZCP – Clinical Memorandum – Therapeutic use of psychedelic substances | May 2020. The Application and Interim Decision.

Therapy 52

Therapy Medicine Environment Conditions 52

NORML

JANUARY 19, 2020

Update : HB 1648 is scheduled for a public hearing in the House Criminal Justice and Public Safety Committee on 1/23/20 at 1:30pm. Update : HB 1614 is scheduled for a public hearing in the House Criminal Justice and Public Safety Committee on 1/23/20 at 11am. NH resident? Send a message to your lawmakers in support of depenalization.

Legislation 244

Legislation Decriminalization Access Patients 244